Free Trial

Diversified Trust Co Sells 18,018 Shares of Centene Co. (NYSE:CNC)

Centene logo with Medical background

Diversified Trust Co reduced its position in Centene Co. (NYSE:CNC - Free Report) by 64.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 9,921 shares of the company's stock after selling 18,018 shares during the period. Diversified Trust Co's holdings in Centene were worth $601,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of CNC. Park Place Capital Corp raised its position in Centene by 1,190.0% in the third quarter. Park Place Capital Corp now owns 387 shares of the company's stock worth $29,000 after acquiring an additional 357 shares during the period. Private Trust Co. NA raised its holdings in Centene by 75.3% in the 3rd quarter. Private Trust Co. NA now owns 773 shares of the company's stock worth $58,000 after purchasing an additional 332 shares during the period. True Wealth Design LLC purchased a new position in Centene during the third quarter valued at $66,000. Venturi Wealth Management LLC increased its position in Centene by 77.3% in the third quarter. Venturi Wealth Management LLC now owns 1,163 shares of the company's stock worth $88,000 after buying an additional 507 shares in the last quarter. Finally, EverSource Wealth Advisors LLC raised its stake in shares of Centene by 104.8% in the second quarter. EverSource Wealth Advisors LLC now owns 1,231 shares of the company's stock worth $82,000 after buying an additional 630 shares during the period. Institutional investors own 93.63% of the company's stock.

Insider Transactions at Centene

In other Centene news, Director Thomas Greco bought 17,000 shares of the business's stock in a transaction dated Wednesday, December 18th. The shares were purchased at an average price of $59.75 per share, with a total value of $1,015,750.00. Following the completion of the purchase, the director now owns 19,309 shares in the company, valued at $1,153,712.75. This represents a 736.25 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CFO Andrew Lynn Asher purchased 17,200 shares of the firm's stock in a transaction that occurred on Wednesday, November 13th. The shares were acquired at an average cost of $58.14 per share, with a total value of $1,000,008.00. Following the completion of the purchase, the chief financial officer now directly owns 486,847 shares in the company, valued at $28,305,284.58. The trade was a 3.66 % increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders purchased 45,010 shares of company stock worth $2,660,276. 0.33% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the stock. Cantor Fitzgerald reissued an "overweight" rating and issued a $90.00 target price on shares of Centene in a report on Wednesday, December 11th. Jefferies Financial Group downgraded shares of Centene from a "hold" rating to an "underperform" rating and decreased their price objective for the company from $68.00 to $52.00 in a research report on Tuesday, December 10th. Stephens dropped their target price on shares of Centene from $75.00 to $73.00 and set an "equal weight" rating for the company in a report on Friday, December 13th. Sanford C. Bernstein lowered their price objective on Centene from $96.00 to $88.00 and set an "outperform" rating on the stock in a research report on Wednesday, October 30th. Finally, StockNews.com cut Centene from a "strong-buy" rating to a "buy" rating in a research report on Monday, October 28th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and ten have issued a buy rating to the company's stock. According to data from MarketBeat, Centene has an average rating of "Moderate Buy" and an average target price of $80.92.

Check Out Our Latest Report on CNC

Centene Price Performance

Shares of NYSE:CNC traded down $1.45 on Friday, reaching $61.72. The company's stock had a trading volume of 5,179,025 shares, compared to its average volume of 4,775,751. The company has a 50-day simple moving average of $60.09 and a 200 day simple moving average of $67.45. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.10 and a current ratio of 1.10. The company has a market cap of $31.16 billion, a P/E ratio of 10.72, a PEG ratio of 0.78 and a beta of 0.45. Centene Co. has a 52-week low of $55.03 and a 52-week high of $81.42.

Centene Company Profile

(Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.

See Also

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Should You Invest $1,000 in Centene Right Now?

Before you consider Centene, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.

While Centene currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why the Latest Jobs Data Has Wall Street Nervous
7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025
3 Stocks Insiders Are Selling, But Analysts Still Love

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines